TAK1

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Signal transduction protein TAB2
US 7153664 B2申请人: MATSUMOTO KUNIHIRO优先权: 1999
US
6 件公开
Method for screening compounds inhibiting signal transduction through inflammatory cytokines
US 6989244 B1申请人: CHUGAI PHARMACEUTICAL CO LTD优先权: 1998
US
4 件公开
5/6-5/6-BISARYL COMPOUNDS AS TAK1 INHIBITORS
EP 4784585 A1申请人: PURDUE RESEARCH FOUNDATION优先权: 2023
CN
EP
WO
3 件公开
TAB1 protein and DNA coding therefore
US 7381543 B2申请人: CHUGAI PHARMACEUTICAL CO LTD优先权: 2002
US
3 件公开
METHODS FOR CANCER TREATMENT USING TAK1 INHIBITORS
US 2009312396 A1申请人: ASTRAZENECA AB优先权: 2006
CN
US
2 件公开
METHODS TO TREAT LYMPHOPLASMACYTIC LYMPHOMA
- EP 3079682 A4
  申请人: DANA FARBER CANCER INST INC优先权: 2013
  EP
  WO
  2 件公开
- US RE50030 E
  申请人: DANA FARBER CANCER INST INC优先权: 2014
  US
Compositions and methods for treatment of retinal degenerative diseases
US 9878021 B2申请人: MOR RESEARCH APPLIC LTD优先权: 2014
CN
US
2 件公开
Tumor microenvironment-related target TAK1 and application thereof in inhibition of tumor
US 11344601 B2申请人: SHANGHAI INST BIOLOGICAL SCIENCES CAS优先权: 2017
CN
US
2 件公开
TARGETING TGF-B-ACTIVATED KINASE-1 ACTIVATION IN THE TREATMENT OF NEUROINFLAMMATORY CONDITIONS
EP 4464318 A1申请人: UNIV FREIBURG ALBERT LUDWIGS优先权: 2023
EP
WO
2 件公开
Tak1-mediated inhibition of osteogenesis
US 2007197457 A1申请人: GAZIT DAN优先权: 2004
US
2 件公开